Document 2817
 DOCN  M94A2817
 TI    Homoeopathic drugs as immuno modulators: a study in 34 HIV subjects.
 DT    9412
 AU    Singh V; Rastogi DP; Dey SK; Rao PK; Regional Research Institute (H),
       Bombay, India.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):218 (abstract no. PB0301). Unique
       Identifier : AIDSLINE ICA10/94369758
 AB    OBJECTIVE: To improve the immunological status through restoring the
       normal CD4 level and clinically control the progression of HIV illness.
       METHODS: Western blot confirmed HIV subjects (34) with immunological
       assessment by peripheral lymphocyte immuno phenotyping of different age
       groups of different sex acquired the infection through heterosexual
       promiscuity (28), blood transfusion (5) and breast feeding (1) were kept
       under homeopathic treatment. Reassessment of immunological value was
       performed after mean interval of six months. Comparative values were
       analysed keeping in view of haematological/clinical status. RESULTS:
       Total Cases--34 (Male-32 & Female-2). On repetition of CD4 assay the
       improvement was noticed in 23 cases (67.64%), status quo in 4 cases
       (11.76%) and no improvement in 7 cases (20.58%). The enhancement of CD4+
       upto 10% in 13 cases and above 10% in 10 cases whereas absolute count
       enhancement upto 200 cells in 3 cases and above 200 cells in 13 cases
       were observed. DISCUSSION AND CONCLUSION: The trial of homeopathic
       medicines in 34 cases has shown the improvement of immunological status
       in 23 cases and maintaining status quo in 4 cases. The haematological
       values were maintained within normal limit without any further
       deterioration in clinical status. Further study among the large number
       of HIV subjects is in progress.
 DE    Adult  Female  *Homeopathy  Human  HIV Infections/IMMUNOLOGY/*THERAPY
       Infant  Leukocyte Count  Male  Treatment Outcome  T4 Lymphocytes
       MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).